Top News Stories

  • Could European data privacy rules cost you big?

    on March 29th, 2018
    U.S. health providers who treat foreign patients may want to take a closer look at their privacy policies to make sure they comply with new European Union data protection rules. May 25 heralds the enforcement of the European Union’s General Data Protection Regulation ( GDPR ), a set of rules desig[...]
  • Ranking points physicians toward South Dakota

    on March 29th, 2018
    South Dakota’s nickname may be the Mount Rushmore State, but for physicians it’s the land of opportunity, according to personal finance website WalletHub. South Dakota took the top spot in the 2018 list of the “best states to practice medicine” with 75.97 out of a possible 100 points while N[...]
  • Oncologist-led BRCA mutation testing and counseling may reduce wait times for women with ovarian cancer

    on March 28th, 2018
    FROM THE JOURNAL OF CLINICAL ONCOLOGY For women with ovarian cancer, an oncologist-led BRCA1/2 (BRCAm) counseling process is associated with favorable waiting times for test results and high levels of satisfaction, according to results of a prospective observational study. The median turnaround time[...]
  • Waning vaccine immunity linked to pertussis resurgence

    on March 28th, 2018
    FROM SCIENCE TRANSLATIONAL MEDICINE The resurgence of whooping cough in the United States could be the result of waning pertussis immunity combined with incomplete historical coverage, researchers said. In the March 28, 2018, edition of Science Translational Medicine , researchers reported on a stud[...]
  • Preprint publishing challenges the status quo in medicine

    on March 27th, 2018
    Like an upstart quick-draw challenging a grizzled gunslinger, preprint servers are muscling in on the once-exclusive territory of scientific journals. These online venues sidestep the time-honored but lengthy peer-review process in favor of instant data dissemination. By directly posting unreviewed [...]
  • TB in 2017: Good news and bad news

    on March 27th, 2018
    FROM MMWR The rate and number of new tuberculosis cases in the United States for 2017 were the lowest since national surveillance started in 1953, but news on the TB elimination front is not so good, according to the Centers for Disease Control and Prevention. Those new lows – TB incidence of 2.8 [...]
  • Top hospital heart failure performance translates to longer survival

    on March 24th, 2018
    REPORTING FROM ACC 2018 ORLANDO (FRONTLINE MEDICAL NEWS) – Hospitals in the first quartile of short-term performance in treating heart failure patients had higher long-term survival rates for those patients, based on data from 317 hospitals that participated in a voluntary quality improvement prog[...]
  • Efavirenz-based ART may hamper vaginal ring contraception

    on March 24th, 2018
    REPORTING FROM CROI 2018 BOSTON (FRONTLINE MEDICAL NEWS) – Efavirenz-based antiretroviral therapy may significantly impair the effectiveness of vaginal ring contraceptives, investigators reported. Over a 21-day period, levels of estrogen among women who used a vaginal ring (NuvaRing) while on efav[...]
  • VIDEO: PFO closure device 100% effective against future strokes

    on March 23rd, 2018
    REPORTING FROM ACC 18 ORLANDO (FRONTLINE MEDICAL NEWS) – Closing a patent foramen ovale reduced the incidence of stroke and other adverse events in patients at increased risk the DEFENSE-PRO trial. “The potential association between patent foramen ovale [PFO] and cryptogenic stroke has been a co[...]
  • Is kratom the answer to the opioid crisis?

    on March 23rd, 2018
    As the opioid epidemic continues to ravage the United States, patients and physicians are looking for less-addictive alternatives for pain control. For a growing number of U.S. patients, top among the contenders is kratom, a plant-based product that shows a dose-dependent opioidlike effect. For phys[...]
  • Siponimod trial ‘first’ to show delayed disability in secondary progressive MS

    on March 22nd, 2018
    FROM THE LANCET Phase 3 data with siponimod, Novartis’ investigational treatment for multiple sclerosis, show a 21% reduction in the time to disease progression versus placebo in patients with the secondary progressive subtype of the disease. A significantly lower percentage of patients with secon[...]
  • Genetic Pap tests catch more cancers

    on March 21st, 2018
    FROM SCIENCE TRANSLATIONAL MEDICINE A Pap test combined with assays for gene mutations showed an 81% and 33% sensitivity or identifying endometrial and ovarian cancer, respectively. In a study published in Science Translational Medicine , Yuxuan Wang, MD , of Johns Hopkins University, Baltimore, and[...]
  • Alternative oxygen therapy reduces treatment failure in bronchiolitis

    on March 21st, 2018
    FROM THE NEW ENGLAND JOURNAL OF MEDICINE High-flow oxygen therapy outside the ICU boosts the likelihood that infants with bronchiolitis will avoid treatment failure and an escalation of treatment, a study finds. “High flow can be safely used in general emergency wards and general pediatric ward se[...]
Back to top